Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)
CNY 7.75
(-0.64%)
CNY 7.75
(-0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 476.56 Million | 734.54 Million | 1.05 Billion | 1.09 Billion | 1.19 Billion | 1.42 Billion |
| Cost of Revenue | 140.93 Million | 171.6 Million | 182.12 Million | 177.34 Million | 176.79 Million | 195.95 Million |
| Gross Profit | 335.63 Million | 562.93 Million | 868.68 Million | 916.88 Million | 1.01 Billion | 1.23 Billion |
| Operating Expenses | 213.89 Million | 527.77 Million | 767.04 Million | 782.63 Million | 884.98 Million | 936.65 Million |
| Selling, General and Administrative Expenses | 251.45 Million | 385.16 Million | 607.26 Million | 645.54 Million | 773.36 Million | 842.47 Million |
| Research and Development Expenses | 77.73 Million | 100.63 Million | 103.84 Million | 71.67 Million | 50.38 Million | 31.92 Million |
| Other Expenses | -115.28 Million | 133.2 Million | 149.82 Million | 13.39 Million | 1.01 Million | -148.03 Thousand |
| Cost and Expenses | 354.83 Million | 699.38 Million | 949.16 Million | 959.97 Million | 1.06 Billion | 1.13 Billion |
| Operating Income | 121.73 Million | 254.63 Million | 438.99 Million | 179.91 Million | 177.16 Million | 330.76 Million |
| Interest Expense | 55.26 Thousand | 33.99 Thousand | 255.18 Thousand | 177.42 Thousand | 140.62 Thousand | 1.13 Million |
| Income Tax Expense | 25.75 Million | 51.96 Million | 43.88 Million | 28 Million | 25.18 Million | 47.45 Million |
| Earnings before Tax | 75.24 Million | 254.61 Million | 439.02 Million | 179.28 Million | 172.73 Million | 330.61 Million |
| Net Income | 102.91 Million | 204.73 Million | 402.27 Million | 154.9 Million | 148.63 Million | 283.1 Million |
| Earnings Per Share Basic | 0.21 | 0.43 | 0.84 | 0.32 | 0.31 | 0.59 |
| Earnings Per Share Diluted | 0.21 | 0.43 | 0.84 | 0.32 | 0.31 | 0.59 |
| Weighted Average Shares Outstanding | 490.08 Million | 481.66 Million | 481.66 Million | 481.66 Million | 481.66 Million | 479.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 490.08 Million | 481.66 Million | 481.66 Million | 481.66 Million | 481.66 Million | 479.84 Million |
| Gross Margin | 0.70 | 0.77 | 0.83 | 0.84 | 0.85 | 0.86 |
| EBIT Margin | 0.02 | 0.11 | 0.43 | 0.20 | 0.13 | 0.23 |
| Profit Margin | 0.22 | 0.28 | 0.38 | 0.14 | 0.12 | 0.20 |
| EBITDA | 7.7 Million | 71.63 Million | 451.22 Million | 160.54 Million | 158.36 Million | 326.81 Million |
| Earnings Before Tax Margin | 0.26 | 0.35 | 0.42 | 0.16 | 0.15 | 0.23 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 108.04 Million | 105.3 Million | 108.82 Million | 476.56 Million | 82.74 Million | 121.78 Million |
| Cost of Revenue | 36.21 Million | 36.84 Million | 37.16 Million | 140.93 Million | 28.23 Million | 36.27 Million |
| Gross Profit | 71.83 Million | 68.46 Million | 71.66 Million | 335.63 Million | 54.5 Million | 85.51 Million |
| Operating Expenses | 63.91 Million | 64.48 Million | 66.95 Million | 376.66 Million | 115.22 Million | 77.74 Million |
| Selling, General and Administrative Expenses | 75.89 Million | 26.6 Million | 57.78 Million | - | 48.77 Million | 86.2 Million |
| Research and Development Expenses | 15.38 Million | 15.66 Million | 9.16 Million | - | 23.44 Million | 11.9 Million |
| Other Expenses | -27.36 Million | -395.44 Thousand | -1100.00 | 72.49 Million | 72.47 Million | -187.59 Million |
| Cost and Expenses | 100.12 Million | 101.32 Million | 104.11 Million | 517.6 Million | 143.46 Million | 114.01 Million |
| Operating Income | 7.89 Million | 95.87 Million | 4.71 Million | 121.73 Million | -94.32 Million | -61.45 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.99 Million | 11.4 Million | -32.69 Million | 25.75 Million | 2.96 Million | -5.2 Million |
| Earnings before Tax | 8.05 Million | 95.48 Million | -134.1 Million | 122.16 Million | -93.91 Million | -61.46 Million |
| Net Income | 6.95 Million | 85.46 Million | -190.61 Million | 102.91 Million | -93.6 Million | -55.13 Million |
| Earnings Per Share Basic | 0.01 | 0.18 | -0.40 | - | -0.19 | -0.11 |
| Earnings Per Share Diluted | 0.01 | 0.18 | -0.40 | - | -0.19 | -0.11 |
| Weighted Average Shares Outstanding | 481.66 Million | 481.66 Million | 481.66 Million | 490.08 Million | 481.66 Million | 481.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 481.66 Million | 481.66 Million | 481.66 Million | 490.08 Million | 481.66 Million | 481.66 Million |
| Gross Margin | 0.66 | 0.65 | 0.66 | 0.70 | 0.66 | 0.70 |
| EBIT Margin | 0.07 | -0.52 | 1.43 | - | 0.41 | -1.13 |
| Profit Margin | 0.06 | 0.81 | -1.75 | 0.22 | -1.13 | -0.45 |
| EBITDA | 7.91 Million | -55.16 Million | 155.24 Million | - | 33.94 Million | -138.22 Million |
| Earnings Before Tax Margin | 0.07 | 0.91 | 0.04 | 0.26 | -1.14 | -0.50 |
DELTA
VANI
FDR
LHHOTEL
2497
002968